Literature DB >> 26458415

Creating a Meeting Point of Understanding: Interpreters' Experiences in Swedish Childhood Cancer Care.

Johanna Granhagen Jungner1, Elisabet Tiselius2, Kim Lützén3, Klas Blomgren3, Pernilla Pergert3.   

Abstract

PURPOSE: Children and families with a foreign background and limited Swedish proficiency have to communicate through interpreters in childhood cancer care centers in Sweden. Interpreter-mediated events deal with many difficulties that potentially hinder the transfer of information. The purpose of our study was to explore interpreters' experiences of interpreting between health care staff and limited Swedish proficiency patients/families in childhood cancer care.
DESIGN: Using purposive samples, we interviewed 11 interpreters individually. The interviews were analyzed using qualitative content analysis.
FINDINGS: Analyses of the data resulted in the main theme of creating a meeting point of understanding, constructed from 3 subthemes: balancing between cultures, bridging the gaps of knowledge, and balancing between compassion and professionalism. DISCUSSION: Our result shows that in order to create a sustainable meeting point of understanding, it is necessary to explain both the context and cultural differences. These results suggest that the responsibility for information transfer lies with both the health care profession and the interpreters. Tools have to be developed for both parties to contribute to creating the meeting point of understanding.
© 2015 by Association of Pediatric Hematology/Oncology Nurses.

Entities:  

Keywords:  cancer; communication; culture; pediatric care

Mesh:

Year:  2015        PMID: 26458415     DOI: 10.1177/1043454215600148

Source DB:  PubMed          Journal:  J Pediatr Oncol Nurs        ISSN: 1043-4542            Impact factor:   1.636


  1 in total

1.  The evolution of a healthcare interpreting service mapped against the bilingual health communication model: a historical qualitative case study.

Authors:  Alexander Bischoff
Journal:  Public Health Rev       Date:  2020-08-04
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.